Additionally, DNASE1L3 impeded HCC progression by binding to beta-catenin thereby promoting its ubiquitination degradation and subsequently suppressing downstream signaling pathways involved in cell cycle and EMT (Li, et al., 2022). The gene discussed is DNASE1L3; the disease is hepatocellular carcinoma.